Identification of genes and pathways involved in kidney renal clear cell carcinoma

BMC Bioinformatics

Volumn 15, Issue 17, 2014, Pages

  Yang, William ^a   Yoshigoe, Kenji ^a   Qin, Xiang ^b   Liu, Jun S ^c   Yang, Jack Y ^d,f   Niemierko, Andrzej ^d   Deng, Youping ^e   Liu, Yunlong ^f   Dunker, A Keith ^f   Chen, Zhongxue ^g   Wang, Liangjiang ^h   Xu, Dong ⁱ   Arabnia, Hamid R ^j   Tong, Weida ^k   Yang, Mary Qu ^a,l  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g INDIANA UNIVERSITY   (United States)

^h CLEMSON UNIVERSITY   (United States)

ⁱ Department of Electrical Engineering and Computer Science   (United States)

^j University of Georgia   (United States)

^k NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^l University of Arkansas at Little Rock   (United States)

more..

Author keywords

Differentially Expressed Genes; Gene Network Analysis; Kidney Renal Clear Cell Carcinoma; Machine Learning Classifier; Pathways; RNA Seq; TCGA

Indexed keywords

ARTIFICIAL INTELLIGENCE; BIOLOGICAL ORGANS; CELLS; CHEMOTHERAPY; COMPUTATIONAL METHODS; CYTOLOGY; DIAGNOSIS; DISEASES; GENES; LEARNING SYSTEMS; RNA;

CLEAR CELL CARCINOMA; DIFFERENTIALLY EXPRESSED GENE; GENE NETWORKS; PATHWAYS; TCGA;

GENE EXPRESSION;

TUMOR MARKER;

CASE CONTROL STUDY; CLUSTER ANALYSIS; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; SUPPORT VECTOR MACHINE;

BIOMARKERS, TUMOR; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KIDNEY; KIDNEY NEOPLASMS; SIGNAL TRANSDUCTION; SUPPORT VECTOR MACHINE;

EID: 84961639706     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-15-S17-S2     Document Type: Article

References (23)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013, 63 (1): 11-30. 10.3322/caac.21166.
2. Linehan WM, Walther MM, Zbar B: The genetic basis of cancer of the kidney. The Journal of urology. 2003, 170 (6 Pt 1): 2163-2172.
3. Kitamura H, Honma I, Torigoe T, Asanuma H, Sato N, Tsukamoto T: Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma. The Journal of urology. 2007, 177 (4): 1269-1272. 10.1016/j.juro.2006.11.082. discussion 1272
4. Mickisch GH: Principles of nephrectomy for malignant disease. BJU international. 2002, 89 (5): 488-495. 10.1046/j.1464-410X.2002.02654.x.
5. Janzen NK, Kim HL, Figlin RA, Belldegrun AS: Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. The Urologic clinics of North America. 2003, 30 (4): 843-852. 10.1016/S0094-0143(03)00056-9.
6. Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL: Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes & cancer. 2010, 1 (2): 152-163. 10.1177/1947601909359929.
7. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013, 499 (7456): 43-49. 10.1038/nature12222.
8. Robinson MD, Smyth GK: Moderated statistical tests for assessing differences in tag abundance. Bioinformatics (Oxford, England). 2007, 23 (21): 2881-2887. 10.1093/bioinformatics/btm453.
9. Robinson MD, McCarthy DJ, Smyth GK: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England). 2010, 26 (1): 139-140. 10.1093/bioinformatics/btp616.
10. Jacques P, Elewaut D: Tumor necrosis factor alpha-induced proteins: natural brakes on inflammation. Arthritis and rheumatism. 2012, 64 (12): 3831-3834. 10.1002/art.34664.
11. Teng YC, Lee CF, Li YS, Chen YR, Hsiao PW, Chan MY, Lin FM, Huang HD, Chen YT, Jeng YM: Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer research. 2013, 73 (15): 4711-4721. 10.1158/0008-5472.CAN-12-3165.
12. Cao J, Liu Z, Cheung WK, Zhao M, Chen SY, Chan SW, Booth CJ, Nguyen DX, Yan Q: Histone demethylase RBP2 is critical for breast cancer progression and metastasis. Cell reports. 2014, 6 (5): 868-877. 10.1016/j.celrep.2014.02.004.
13. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature genetics. 2000, 25 (1): 25-29. 10.1038/75556.
14. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research. 2000, 28 (1): 27-30. 10.1093/nar/28.1.27.
15. Andrew Gross MC, Shen John, James Michael Randall, Trey Ideker, Matan Hofree, University of California, San Diego, La Jolla CA, UC San Diego Moores: Association of methylation of genes in the taurine/hypotaurine pathway with worse prognosis in renal cell carcinoma. J Clin Oncol. 2013, 31:
16. Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L: Risk for renal cell carcinoma in chronic hepatitis C infection. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010, 19 (4): 1066-1073. 10.1158/1055-9965.EPI-09-1275.
17. Hofmann JN, Torner A, Chow WH, Ye W, Purdue MP, Duberg AS: Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2011, 20 (4): 326-330. 10.1097/CEJ.0b013e32834572fa.
18. Wiwanitkit V: Renal cell carcinoma and hepatitis C virus infection: is there any cause-outcome relationship?. Journal of cancer research and therapeutics. 2011, 7 (2): 226-227. 10.4103/0973-1482.82931.
19. Lou S, Ren L, Xiao J, Ding Q, Zhang W: Expression profiling based graph-clustering approach to determine renal carcinoma related pathway in response to kidney cancer. European review for medical and pharmacological sciences. 2012, 16 (6): 775-780.
20. Oya M, Ohtsubo M, Takayanagi A, Tachibana M, Shimizu N, Murai M: Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene. 2001, 20 (29): 3888-3896. 10.1038/sj.onc.1204525.
21. Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, Marumo K, Shimizu N, Murai M: Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis. 2003, 24 (3): 377-384. 10.1093/carcin/24.3.377.
22. Wu X, Zhang W, Font-Burgada J, Palmer T, Hamil AS, Biswas SK, Poidinger M, Borcherding N, Xie Q, Ellies LG: Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade. Proceedings of the National Academy of Sciences of the United States of America. 2014
23. Falcon S, Gentleman R: Using GOstats to test gene lists for GO term association. Bioinformatics (Oxford, England). 2007, 23 (2): 257-258. 10.1093/bioinformatics/btl567.